Department of Veterinary Public Health and Preventive Medicine, University of Jos, Jos, Nigeria.
Department of Parasitology and Entomology, Modibbo Adama University of Technology, Yola, Nigeria.
Pathog Glob Health. 2022 Jun;116(4):220-235. doi: 10.1080/20477724.2021.1989185. Epub 2021 Nov 17.
Human babesiosis is an emerging tick-borne protozoan zoonosis caused by parasites of the genus and transmitted by ixodid ticks. It was thought to be a public health problem mainly for the immunocompromised, however the increasing numbers of documented cases among immunocompetent individuals is a call for concern. In this systematic review and meta-analysis, we reported from 22 countries and 69 studies, an overall pooled estimate (PE) of 2.23% (95% CI: 1.46-3.39) for infections in humans. PEs for all sub-groups varied significantly (p < 0.05) with a continental range of 1.54% (95% CI: 0.89-2.65) in North America to 4.17% (95% CI: 2.11-8.06) in Europe. PEs for country income levels, methods of diagnosis, study period, sample sizes, species and targeted population ranged between 0.43% (95% CI: 0.41-0.44) and 7.41% (95% CI: 0.53-54.48). recorded the widest geographic distribution and was the predominant specie reported in North America while was predominantly reported in Europe. Eight species; -like, and were reported in humans from different parts of the world with the highest prevalence in Europe, lower middle income countries and among individuals with history of tick bite and other tick-borne diseases. To control the increasing trend of this emerging public health threat, tick control in human settlements, the use of protective clothing by occupationally exposed people and the screening of transfusion blood in endemic countries are recommended. AJOL: African Journals OnLine, CI: Confidence interval, CIL: Country income level, df: Degree of freedom, HIC: Higher-income countries, HQ: High quality, : Inverse variance index, IFAT: Indirect fluorescent antibody test, ITBTBD: Individuals with tick-bite and tick-borne diseases, JBI: Joanna Briggs Institute, LIC: Lower-income countries, LMIC: Lower middle-income countries, MQ: Medium quality, NA: Not applicable, N/America: North America, OEI: Occupational exposed individuals, OR: Odds ratio, PE: Pooled estimates, PCR: Polymerase chain reaction, Prev: Prevalence, PRISMA: Preferred Reporting System for Systematic Reviews and Meta-Analyses, Q: Cochran's heterogeneity statistic, QA: Quality assessment, Q-p: Cochran's p-value, qPCR: Quantitative polymerase chain reaction, S/America: South America, Seq: Sequencing, UMIC: Upper middle-income countries, USA: United States of America.
人类巴贝虫病是一种由 和 属寄生虫引起的新兴蜱传原生动物人畜共患病,由硬蜱传播。它曾被认为是一个主要的免疫功能低下人群的公共卫生问题,然而,越来越多的免疫功能正常人群中确诊的病例引起了人们的关注。在这项系统评价和荟萃分析中,我们报道了来自 22 个国家和 69 项研究的结果,人类感染的总体合并估计值(PE)为 2.23%(95%CI:1.46-3.39)。所有亚组的 PE 差异均有统计学意义(p<0.05),北美的范围为 1.54%(95%CI:0.89-2.65),欧洲为 4.17%(95%CI:2.11-8.06)。按国家收入水平、诊断方法、研究期、样本量、 种类和目标人群划分的 PE 值范围在 0.43%(95%CI:0.41-0.44)至 7.41%(95%CI:0.53-54.48)之间。 记录的地理分布最广,是北美的主要报告物种,而 则主要在欧洲报告。来自世界各地的八种 物种; 、 和 在人类中被报道,在欧洲、中低收入国家和有蜱叮咬和其他蜱传疾病史的人群中,其流行率最高。为了控制这种新出现的公共卫生威胁的上升趋势,建议在人类住区进行蜱控制,职业暴露人群使用防护服,并在流行国家筛查输血血液。AJOL:非洲期刊在线,CI:置信区间,CIL:国家收入水平,df:自由度,HIC:高收入国家,HQ:高质量, :方差指数,IFA:间接荧光抗体试验,ITBTBD:蜱叮咬和蜱传疾病个体,JBI:乔安娜·布里格斯研究所,LIC:低收入国家,LMIC:中低收入国家,MQ:中等质量,NA:不适用,NAmerica:北美,OEI:职业暴露个体,OR:优势比,PE:合并估计值,PCR:聚合酶链反应,Prev:患病率,PRISMA:系统评价和荟萃分析的首选报告系统,Q:Cochran's 异质性统计量,QA:质量评估,Q-p:Cochran's p 值,qPCR:定量聚合酶链反应,S/America:南美洲,Seq:测序,UMIC:上中等收入国家,USA:美利坚合众国。